News Results
There are 197,510 News Results
May 3, 2024
Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the first quarter of 2024. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are...
May 6, 2024
Northwest Natural Holding Company, (NYSE: NWN) (NW Natural Holdings), reported financial results and highlights including: Reported net income of $63.8 million ($1.69 per share) for the first quarter of 2024,...
May 7, 2024
Atkore Inc. (the “Company” or “Atkore”) (NYSE: ATKR) announced earnings for its fiscal 2024 second quarter ended March 29, 2024. “Atkore achieved solid results in the second quarter having met...
May 7, 2024
USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for first-quarter 2024. Financial Highlights Record total revenues of $229.3 million for...
May 9, 2024
Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended March 31, 2024. On November 30, 2023, Mativ Holdings, Inc. (“Mativ” or the...
May 9, 2024
Piedmont Lithium Inc. (“Piedmont,” the “Company,” "we," "our," or "us") (Nasdaq: PLL; ASX: PLL), a leading North American supplier of lithium products critical to the U.S. electric vehicle supply chain,...
May 10, 2024
Clean Energy Fuels Corp. (NASDAQ: CLNE) (“Clean Energy” or the “Company”) today announced its operating results for the first quarter of 2024. Financial Highlights Revenue of $103.7 million in Q1...
May 10, 2024
Granite Ridge Resources Inc. (“Granite Ridge” or the “Company”) (NYSE: GRNT) today reported financial and operating results for the first quarter of 2024. First Quarter 2024 Highlights Grew production 3%...
May 13, 2024
Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Financial Officer, Ingo Hofmaier, are pleased to provide an overview of Lifezone’s achievements during the past quarter and...
Jan 5, 2024
--ARIKAYCE(®) (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales of Approximately $305.2 Million-- --2024 Global ARIKAYCE Revenues...
